Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Two Endoscopic Treatments for Small Rectal Neuroendocrine Tumors

Official title: Retrospective Comparative Study of Two Different Endoscopic Treatments for Rectal Neuroendocrine Neoplasms

Run by Jilin University · NCT07612748 · Data updated 2026-11-12

This study compares two endoscopic techniques to see which safely and effectively treats small rectal neuroendocrine tumors (R-NENs).

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment483 (estimated)
SponsorJilin University
Academic / other
Locations2 sites (Changchun, Jilin and 1 other locations)
StatusRecruiting
StartedJune 1, 2026
Main results expectedNovember 1, 2026
Study endsDecember 1, 2027
Registry record updatedJune 3, 2026
Trial IDNCT07612748 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with rectal neuroendocrine neoplasms measuring less than 2 cm, without lymph node or distant metastasis, suitable for either ESD or EPMR.

Probably not a fit

Patients whose tumors are unsuitable for ESD or EPMR, or who have metastases or other exclusion criteria, may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers looked back at patients treated for rectal neuroendocrine neoplasms between 2020 and 2026, comparing endoscopic submucosal dissection (ESD) with endoscopic partial muscle resection (EPMR). They examined lesion number, size, procedure time, complications, margins, staging, lymphovascular invasion, and need for additional therapy to determine which method yields better outcomes. The analysis aimed to identify the optimal approach for endoscopic treatment of R-NENs smaller than 2 cm without metastasis. No randomization was performed; findings reflect retrospective experience from a single center. Results could guide future choices in endoscopic therapy for these tumors.

Why it matters

Potential benefit: If successful, patients may receive a clearer, safer endoscopic option tailored to small rectal neuroendocrine tumors.

How similar studies have gone: Prior research suggests endoscopic techniques can be effective for small rectal neuroendocrine tumors, but direct head-to-head comparisons like this are relatively limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients undergoing endoscopic treatment for rectal neuroendocrine neoplasms.
* Lesion diameter less than 2 cm.
* Preoperative auxiliary examinations indicating no peripheral lymph node or distant metastasis.
* Endoscopic surgical approach limited to ESD or EPMR.

Exclusion Criteria:

* Use of non-ESD or non-EPMR endoscopic techniques, such as ligation-assisted resection or Endoscopic Mucosal Resection (EMR).
* Presence of other conditions deemed by the investigator to be unsuitable for participation in this study.
* Patient or family refusal to participate.

Where it's running

  • the First Hospital of Jilin University
    Changchun, Jilin, China
    Recruiting
  • the First Hospital of Jilin University
    Changchun, China
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.